ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 406 filers reported holding ENCOMPASS HEALTH CORP in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,412,833 | -49.7% | 36,608 | -48.7% | 0.00% | -42.9% |
| Q2 2023 | $4,794,980 | +126.9% | 71,407 | +82.8% | 0.01% | +133.3% |
| Q1 2023 | $2,113,687 | +26.5% | 39,070 | +39.8% | 0.00% | 0.0% |
| Q4 2022 | $1,671,032 | +390.0% | 27,939 | +270.4% | 0.00% | +200.0% |
| Q3 2022 | $341,000 | +18.0% | 7,543 | +16.4% | 0.00% | – |
| Q2 2022 | $289,000 | -65.4% | 6,482 | -49.3% | 0.00% | -100.0% |
| Q4 2021 | $835,000 | -35.6% | 12,792 | -25.9% | 0.00% | -50.0% |
| Q3 2021 | $1,296,000 | +468.4% | 17,274 | +491.2% | 0.00% | – |
| Q2 2021 | $228,000 | -7.3% | 2,922 | -2.9% | 0.00% | – |
| Q1 2021 | $246,000 | +8.8% | 3,009 | +9.9% | 0.00% | – |
| Q4 2020 | $226,000 | -83.2% | 2,737 | -88.1% | 0.00% | -100.0% |
| Q1 2019 | $1,344,000 | +23.9% | 23,015 | +30.9% | 0.00% | 0.0% |
| Q4 2018 | $1,085,000 | +386.5% | 17,577 | +514.2% | 0.00% | +200.0% |
| Q3 2018 | $223,000 | – | 2,862 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |